Navigation Links
PFC SIGMA Fixed Bearing Knee System Cruciate - Substituting

ProductsPFC SIGMA Fixed Bearing Knee System Cruciate - Substituting
Company DePuy Orthopaedics, Inc.
Item PFC SIGMA Fixed Bearing Knee System Cruciate - Substituting
Features 
  • Patented cam and spine design provides true mechanical substitution for the PCL to produce component rollback
  • Its central location transfers shear forces into compression through center stem of tibial component
  • Provides high liftoff value (16.3mm) before femoral component subluxes over tibial spine
  • Uniform femoral box/tibial spine dimensions across size range provide for interchange-ability, one size up and down.
  • Same component can be used for primary CS or revision procedures with the addition of modular stems and augments
  • Revision procedures do not require any additional bone resection
  • Three offset stem/bolt positions (0mm, +/- 2mm), allows accurate femoral component placement based on IM canal.
  • Rounded coronal shape of posterior stabilized tibial insert maximizes contact area and reduces peak stresses avoiding edge loading with rounded femoral condyles
  • Reinforcement pin helps reinforce against high varus/valgus loads insert is subjected to when collateral support is lacking
  • Description The P.F.C. Sigma Total Knee System is designed to provide the surgeon with surgical solutions for a variety of clinical indications. Based on the clinically successful P.F.C. Total Knee System introduced in 1984, P.F.C. Sigma continues a history of innovation. Indicated for procedures where mechanical substitution is required for the posterior cruciate ligament, the cruciate substituting components may be used for primary or revision procedures. The femoral component is modular, allowing for the addition of stems and augments in revision procedures. SPECIALIST 2 Instruments provide for an easy transition from cruciate retaining to cruciate substituting in revision procedures.
    Info DePuy Orthopaedics, Inc.
    Customer Service: (800) 366-8143
    Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

    Related medicine products :

    1. PFC SIGMA Fixed Bearing Knee System Cruciate - Retaining
    2. PFC SIGMA RP Rotating Platform Knee System
    3. Straight Fixed Core Wire Guides
    4. Small Anatomy Fixed Curve Catheters
    5. Inquiry Fixed Curve Diagnostic Catheters
    6. Webster Small Anatomy Fixed Curve Catheters
    7. Webster Supra CS Decapolar (Coronary Sinus Fixed Curve Catheters)
    8. Explorer ST Fixed Curve Diag. Catheters
    9. Webster Santoro 20 Pole Fixed Curve Catheter
    10. Luma-Cath Lumen Diagnostic Mapping Catheters Fixed and Steerable Curves
    11. Webster Luminal Decapolar (Coronary Sinus Fixed Curve Catheters)
    The CIC Pro Clinical Information Center brings together vital patient information from multiple monitoring devices....
    ... Alaris System integrates drug infusion,with patient ... a single, modular platform. With multiple ... modules as you,need them, keeping the ... a minimum while managing the unique ...
    ... Gemini Family of infusion pumps ... a collective series of administration ... line offers a wide variety ... sets, each featuring the patented ...
    ... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
    Medicine Products:
    (Date:11/27/2014)... At The Little Gym, we know that being ... surprise when a recent study confirmed that regular physical ... Journal of Pediatrics found that “Promoting physical activity ... school years may be important not only for health, ... two groups of children; those that were engaging in ...
    (Date:11/27/2014)... 27, 2014 Ethane Web Technologies, which ... announced online reputation management service. , The company ... about the world of internet marketing and algorithms of ... , Ethane Web Technologies does not work with the ... the project to reach a conclusion what will work ...
    (Date:11/27/2014)... November 27, 2014 VeloReality Inc. ... new Real Life Videos (RLVs) of world-famous velo courses for ... as well as other popular indoor velo trainers. Two dozen ... worldwide before the end of November -- in time ... total number of rides in the VeloReality collection to over ...
    (Date:11/27/2014)... (PRWEB) November 27, 2014 Serious Buyer, ... for vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum concert posters. ... bands played at the University of Alabama. Jimi Hendrix ... to Hawley, “It started with Gary Weinberger who was ... at University Programs Council. The council was responsible for ...
    (Date:11/26/2014)... Angeles, CA (PRWEB) November 26, 2014 ... to treat themselves this holiday season! With Parsa Mohebi ... incredible 10% off of their next FUE procedure, making ... transplant. , FUE—which stands for “Follicular Unit Extraction”—is an ... advantages over traditional “strip” Follicular Unit Transplantation (FUT). FUE, ...
    Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3Health News:Serious Buyer Announces His Search For Vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum Concert Posters 2Health News:FUE Special at Parsa Mohebi Hair Restoration This Holiday Season 2
    ... , SILVER SPRING, Md., Aug. 21 ... from People for the Ethical Treatment of Animals (PETA) promoting vegetarianism ... billboard ad displays an image of an overweight woman in a ... Blubber: Go Vegetarian ." This ad is an unmistakable example of ...
    ... , , ATLANTA, Aug. 21 ... ceremony is to take place August 27, 2009 in Milledgeville, GA. ... Fund Commission announces its annual meeting will take place on Thursday, ... Military College - Legislative Chamber/Old Capitol Building in Milledgeville, GA. The ...
    ... , , LOS ANGELES, Aug. 21 ... of 2009 (Recovery Act) grants totaling $19.4 million from the National ... date was $1.9 million, awarded to UCLA,s Laboratory of Neuro Imaging ... the brain is structured and how it works. , ...
    ... CHICAGO, Aug. 21 Illinois U.S. Senate candidate Cheryle Jackson today ... the dual goals of containing costs and expanding access to quality ... Jackson said that health care cooperatives are not a ... public plan that competes with the private insurance industry because cooperatives ...
    ... , ... Help Plans Attract, Retain and Serve Health Insurance Consumers , ... Orlando, FL (Vocus) August 21, 2009 ... health coverage. This is making individual consumers become more involved in the health insurance ...
    ... Los Angeles, London, New Delhi, Singapore and Washington DC (August ... tumours could benefit from a lighter touch but from ... have created a touchy-feely robot that detects tougher tumour tissue ... a human. The technique also minimises tissue damage. Surgeons ...
    Cached Medicine News:Health News:The Obesity Society Calls Billboard Campaign Offensive and Off-Target 2Health News:Brain and Spinal Injury Trust Fund Commission Annual Meeting and Award Ceremony 2Health News:UCLA Awarded More Than $19 Million In NIH Stimulus Funds 2Health News:U.S. Senate Candidate Cheryle Jackson: 'Public Option Critical to Real Health Care Reform' 2Health News:Connextions Cited in Leading Industry Analyst Firm's 'Hype Cycle for Healthcare Payers' 2Health News:Connextions Cited in Leading Industry Analyst Firm's 'Hype Cycle for Healthcare Payers' 3Health News:Connextions Cited in Leading Industry Analyst Firm's 'Hype Cycle for Healthcare Payers' 4Health News:Robot's gentle touch aids delicate cancer surgery 2Health News:Robot's gentle touch aids delicate cancer surgery 3
    (Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
    (Date:11/26/2014)... Calif. and LONDON , Nov. ... and AstraZeneca (NYSE: AZN ) today announced that ... two doses of brodalumab in more than 1,800 patients with ... both Stelara ® (ustekinumab) and placebo at week 12. ... weight-based analysis group were each shown to be superior to ...
    (Date:11/26/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 3, 2014 ... Helen Torley , President and Chief Executive Officer, will provide ... through the "Investors" section of Halozyme,s corporate website at ... 90 days following the event. To access the live webcast, ...
    Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2